Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repair.

Spraggon L, Martelotto LG, Hmeljak J, Hitchman TD, Wang J, Wang L, Slotkin EK, Fan PD, Reis-Filho JS, Ladanyi M.

J Pathol. 2017 May;242(1):102-112. doi: 10.1002/path.4883. Epub 2017 Mar 30.

2.

Quaternary Ti-20Nb-10Zr-5Ta alloy during immersion in simulated physiological solutions: formation of layers, dissolution and biocompatibility.

Milošev I, Hmeljak J, Žerjav G, Cör A, Calderon Moreno JM, Popa M.

J Mater Sci Mater Med. 2014 Apr;25(4):1099-114. doi: 10.1007/s10856-014-5144-1. Epub 2014 Jan 23.

PMID:
24452270
3.

Is survivin expression prognostic or predictive in malignant pleural mesothelioma?

Hmeljak J, Erčulj N, Dolžan V, Pižem J, Kern I, Kovač V, Cemažar M, Cör A.

Virchows Arch. 2013 Mar;462(3):315-21. doi: 10.1007/s00428-013-1373-9. Epub 2013 Jan 29.

PMID:
23358691
4.

Hyaluronic acid stimulates the formation of calcium phosphate on CoCrMo alloy in simulated physiological solution.

Milošev I, Hmeljak J, Cör A.

J Mater Sci Mater Med. 2013 Mar;24(3):555-71. doi: 10.1007/s10856-012-4827-8. Epub 2012 Dec 19.

PMID:
23250579
5.

DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.

Erčulj N, Kovač V, Hmeljak J, Franko A, Dodič-Fikfak M, Dolžan V.

J Thorac Oncol. 2012 Oct;7(10):1609-17. doi: 10.1097/JTO.0b013e3182653d31.

6.

The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.

Erčulj N, Kovač V, Hmeljak J, Franko A, Dodič-Fikfak M, Dolžan V.

Pharmacogenet Genomics. 2012 Jan;22(1):58-68. doi: 10.1097/FPC.0b013e32834e3572.

PMID:
22134350
7.

BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.

Hmeljak J, Erčulj N, Dolžan V, Kern I, Cör A.

J Cancer Res Clin Oncol. 2011 Nov;137(11):1641-51. doi: 10.1007/s00432-011-1030-0. Epub 2011 Aug 23.

PMID:
21861135
8.

The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma.

Erčulj N, Kovač V, Hmeljak J, Dolžan V.

Ann Oncol. 2012 Apr;23(4):961-7. doi: 10.1093/annonc/mdr324. Epub 2011 Jul 15.

PMID:
21765044
9.

No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia.

Hmeljak J, Kern I, Cör A.

Tumori. 2010 Sep-Oct;96(5):667-73.

PMID:
21302609

Supplemental Content

Loading ...
Support Center